Form4insider filings, from the source

SEC Form 4 · accession 0001636178-26-000028

UNITED THERAPEUTICS Corp · UTHR

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
James Edgemond
Officer — CFO AND TREASURER
Period of report
Jun 18, 2026
Accepted (ET)
Jun 22, 2026 · 4:31 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001082554

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockJun 18, 2026M10,000$146.03A28,876D
Common StockF2Jun 18, 2026S400$533.587D28,476D
Common StockF3Jun 18, 2026S160$534.475D28,316D
Common StockF4Jun 18, 2026S210$536.2721D28,106D
Common StockF5Jun 18, 2026S600$537.2397D27,506D
Common StockF6Jun 18, 2026S1,440$538.3079D26,066D
Common StockF7Jun 18, 2026S2,035$539.4173D24,031D
Common StockF8Jun 18, 2026S2,978$540.2175D21,053D
Common StockF9Jun 18, 2026S865$541.0582D20,188D
Common StockF10Jun 18, 2026S192$541.8846D19,996D
Common StockF11Jun 18, 2026S40$543.5268D19,956D
Common StockJun 18, 2026S40$545.19D19,916D
Common StockF12Jun 18, 2026S265$547.3683D19,651D
Common StockF13Jun 18, 2026S115$547.8052D19,536D
Common StockF14Jun 18, 2026S660$548.9021D18,876D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option$146.03Jun 18, 2026M10,000DMar 15, 2020Mar 15, 2027Common Stock10,0008,750D

Explanation of responses